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Abstract 
Relationships between health and economic prosperity or economic growth are difficult to assess. 
The direction of the causality is often questioned and the subject of a vigorous debate. For some 
authors, diseases or poor health had contributed to poor growth performances especially in low-
income countries. For other authors, the effect of health on growth is relatively small, even if one 
considers that investments which could improve health should be done. It is argued in this paper that 
commonly used health indicators in macroeconomic studies (e. g. life expectancy, infant mortality or 
prevalence rates for specific diseases such as malaria or HIV/AIDS) imperfectly represent the global 
health status of population. Health is rather a complex notion and includes several dimensions which 
concern fatal (deaths) and non-fatal issues (prevalence and severity of cases) of illness. The reported 
effects of health on economic growth vary accordingly with health indicators and countries included in 
the analyses. The purpose of the paper is to assess the effect of a global health indicator on growth, the 
so-called disability-adjusted life year (DALY) that was proposed by the World Bank and the WHO in 
1993. Growth convergence equations are run on 159 countries over the 1999-2004’s period, where the 
potential endogeneity of the health indicator is dealt for. The negative effect of poor health on 
economic growth is not rejected thus reinforcing the importance of achieving MDGs. 
 
Keywords: Disease Global Burden, DALYs, economic growth, macroeconomic health 
impact, cross-country analysis  
JEL Codes: E22, E24, I10, I18, O47 
 
3 
 
1. Introduction 
Sen’s works on human capabilities and the emergence of AIDS have renewed the interest 
given to the link between health, welfare, and prosperity. In 2001, the Commission on 
Macroeconomics and Health (2001) concluded that diseases raise barriers to economic growth 
and that countries have to invest in health. Theoretical arguments can also be found in growth 
theory where capital accumulation is meant to drive growth. Human capital investments are 
known for a long time as basic candidates explaining growth performances (e. g. Schultz, 
1961; Mankiw et al. 1992). Recent studies stress either the role of education on income per 
capita growth in Asian emerging countries (Chi, 2008; Kwack and Lee, 2006; Kang, 2006) or 
the effect of health status on growth through its effect on education (Li and Huang, 2009).  
At a microeconomic level2, several studies found that poor health has negative effects on 
economic prosperity and living conditions. A great variety of health indicators are used and 
concern either one specific communicable disease such as Guinea worm, schistosomiasis or 
malaria (Weisbrod and Helminiak, 1977; Audibert, 1986; Audibert, 1997a and 1997b; 
Audibert and Etard, 1998; Girardin et al., 2004), or self-assessed health status relied to 
activities of daily living and to general health (Schultz and Tansel, 1997; Gertler and Gruber, 
2002; Christiaensen, Hoffmann and Sarris, 2007; Liu et al., 2008).  
At a macroeconomic level, several authors consider that communicable diseases, among 
others, had contributed to slow down economic development of low income countries. 
Nevertheless, their affirmation on this negative macroeconomic effect is still hotly debated as 
some methodological issues are not satisfactorily addressed (see the comprehensive and 
critical review of Packard, 2009). Moreover, several studies argue that the negative effect of 
health on growth is not so obvious. Acemoglu and Johnson (2006), using international data 
from the epidemiological transition period, find that an increase in life expectancy generated 
by a decrease in mortality rates had a small positive effect which grows over the post 
epidemiological transition. The latter was not enough important to compensate for increases 
in population. Consequently, life expectancy increases do not lead to a significant increase in 
per capita economic growth. This study makes reminiscent previous results of Barlow (1968) 
with regard to malaria eradication and of Over (1992) with regard to economic effects of 
                                                 
2
 The literature on links between health and economic well-being or prosperity at microeconomic level is 
abundant. Strauss and Thomas (2007) recently did an exhaustive literature review of this topic at microeconomic 
level.   
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AIDS as well. Indeed, Bell, Bruhns and Gersbach (2006), using an overlapping generations 
model simulate relaxed effects of AIDS on economic growth in Kenya by 2050.  
There are at least three reasons that could explain difficulties to accurately assess health 
impacts at the macroeconomic level. First, links between health and development or growth 
are complex and health effects could also be channelled by education, the environment, and 
cultural behaviours as well. When, due to missing adequate indicators, these behaviours are 
not included in the model, the estimated health effects will be biased or hidden by unobserved 
heterogeneity (Thomas, 2009; Strauss and Thomas, 2007). Second, health is subject to 
random measurement errors either due to poor measurement facilities (lack of good 
equipment for setting appropriate diagnosis, low human resource training, lack of good 
registration), measurement variability over the day (e.g. blood pressure) or the year (e. g. 
malaria indicators). Third, health status is a rather complex notion that includes several 
dimensions.  
Despite these difficulties of measuring multiple dimensions of health and therefore global 
health status, macroeconomic effects of health have been more often studied using health 
indicators such as life expectancy at birth, infant mortality rates, or anthropometric measures. 
Studies results can be questioned. For instance, life expectancy at birth is closely related to 
infant mortality or high adult mortality rates, due to AIDS and alcoholism, which is a specific 
and partial aspect of health status. Anthropometric measures focus mainly on nutritional status 
of children which is not representative of overall health status. Our purpose in this article is to 
study the relationship between health and development at the macroeconomic level, by using 
the global health status indicator provided by the World Health Organisation and the World 
Bank, namely the Disability Adjusted Life Years (DALY). 
The rest of the paper is organized as follows. Section 2 is devoted to health measurement 
issues. Different measures of health indicators used in the growth literature are discussed 
before presenting exploring the more global one which is focused on in this study. Section 3 
reviews the theoretical and empirical literature on the link between health outcomes and 
economic performances. The empirical setting and the results are presented in section 4 and 5. 
Section 6 concludes.  
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2. Looking for a global health indicator 
Health measurement is a hard task since, contrary to economic indicators, health is multi-
dimensional3, and measured with errors. Moreover, researchers, either in a perspective of 
public health, health research, or economic health research, have developed a battery of health 
indicators, among which few however are satisfactorily measured (Murray and Frenk, 2008; 
Murray, 2007)4. If it is crucial to understand what each indicator measures (Strauss and 
Thomas, 2008), it is also important to assure that the health indicator used fits the purpose of 
the study. 
The most-used indicators of health conditions at the macroeconomic level are life 
expectancy at birth and infant mortality rates (Strauss and Thomas, 2008). Those indicators 
are considered reflecting the general health conditions and supposed to be positively 
associated with economic growth. It is true that life expectancy is higher and infant mortality 
lower in richer countries than in poorer countries. Indeed, the correlation between life 
expectancy at birth and GDP per capita is not systematic as life expectancy is in some 
countries lower (or higher) than expected given GDP per capita (Southern Africa, Gabon or 
Indonesia, for examples,  Strauss and Thomas, 2008). Over time, per capita incomes have 
diverged while life expectancy and infant mortality have converged (Deaton, 2006; Jack and 
Lewis, 2009). Life expectancy and infant mortality are inadequate indicators of the 
population’s health in high income countries and for some upper middle income countries as 
life expectancy is high and infant mortality very low or low. For low and lower middle 
income countries, those indicators are more adequate due to their poor levels. For that reason, 
studying the relationships between health and economic development or growth in cross-
country studies using infant mortality or life expectancy at birth is not really appropriate.  
The emergence of HIV/AIDS and the highly prevalence (more than 15%) in some southern 
African countries (Botswana, Lesotho, Namibia, South Africa, Swaziland, Zambia, and 
Zimbabwe, UNAIDS5), has motivated several studies focusing on their economic effects. But, 
little evidence of a correlation between HIV/AIDS and GDP per capita was found (Strauss 
and Thomas, 2008). With the renewal interest for malaria, some authors (Sachs and Malaney, 
                                                 
3
 Whatever the approach chosen (medical, self-assessment or functional) for measuring health, poor health is 
considering as a deviation between the observed health and a norm. This deviation may occur into either, 
physical, mental, or social well-being dimension.  
4
 For a discussion on the issue and challenge of health measurement, see Mwabu, 2007; Strauss and Thomas, 
2008; Murray and Frenk, 2008; Audibert, 2009).  
5
 http://www.unaids.org/en/CountryResponses/Regions/SubSaharanAfrica.asp. 
6 
 
2002; McCarthy, Wolf and Wu) focused on the effect of that disease on African countries 
growth. 
As underlined by Jack and Lewis (2009), the effect of a population’s health status on 
national income varies accordingly with the health indicator used. Most health indicators used 
in the literature capture one dimension of the population health. They either relate to fatal 
issues, underlying the rule of rescue (life expectancy6, mortality indicators), or to non-fatal 
ones (morbidity indicators) issue of illness (Audibert, 2009). Those indicators neither take 
into account other dimensions of health, such as invalidity, handicap or social consequences, 
nor multidimensional characteristics of health.  
3. Relationship between health and growth 
The implicit question of the connections between health and growth is twofold: Do 
investments in health boost economic growth; do economic opportunities help to improve 
health? Directions of the causality between health and economic growth are still the subject of 
discussions as well as its bidirectional causality (Jack and Lewis, 2009; Duncan, 2009; Weil, 
2010). Nevertheless, estimating those relations is difficult, specifically in cross-country 
analyses. Several authors like Schultz (2008), argue that there is a need “for a more 
conceptual hypotheses refinement and empirical testing and comprehensive study of specific 
pathways which could improve our knowledge about those causal connections”. Those 
pathways may concern life styles, the environment (social, economic and physical) and health 
services (Aguayo-Rico et al. 2005).  
3.1. Theoretical background 
This paper builds on the idea of health being a capital: people are endowed an initial stock 
which can depreciate through time with age but which is the subject of investments 
(Grossman, 1972; see Mwabu, 2007 for a literature review on the concept of health capital). 
From such a perspective, Van Zon and Muysken (2005) mention two positive effects of health 
on economic growth. First, the health status of population increases the efficiency of labour; 
second, human capital accumulation requires “health hours”. These effects add to those of 
Bloom and Canning (2000) who argue that improvements in longevity increase savings and in 
turn investments; moreover there exists a demographic dividend generated by a decline in 
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 In low income countries, life expectancy is mainly determined by infant mortality, and also in countries where 
AIDS prevalence is high, by AIDS mortality. 
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child mortality. The effect of health on economic growth has also been the subject of 
theoretical investigations. One may refer to the augmented Solow model developed and tested 
by Mankiw et al. (1992). Other authors have included health in optimal Cass-Koopmans like 
growth models and thereby justified its inclusion in conditional convergence analyses as well: 
the productivity in the health sector has a positive impact on all steady state variables 
(Muysken et al. 2003). At last, health investments are taken into account in endogenous 
growth models à la Lucas (1988) with two characteristics: health is produced with decreasing 
returns whereas human capital is built with increasing returns. Health can either be a 
complement or a substitute to growth when the effect of health on longevity is internalised 
(van Zon & Muysken, 2001). Neo-schumpeterian growth models also allow identifying 
several channels through which population health impacts their long run growth performance. 
One of these channels puts forward the ability of health improvements to stabilise the gap in 
living standards relatively to technology leaders (Howitt, 2005). 
3.2. Empirical estimation of the links between health and 
economic growth or prosperity 
The association between income level and population health has been extensively studied 
in the literature for several years. At the macro-level, the apparent link between those two 
variables has been highlighted by the Preston’s curb (1975) which establishes an upward 
shifting relationship between life expectancy and national income per capita between 1900 
and 1960. This correlation however neither gives pieces information on the sense of the 
causality nor on the different channels through which health may impact economic growth.    
These channels may be identified. The first is that healthier people are more productive 
and more efficiently supply labour. Indeed, they can work harder and longer, and think more 
clearly. Health status may also improve economic outcomes through its effect on education. 
Improvements in health raise the motivation to attend high level schooling, since the returns 
to investments in schooling are valuable over a longer working life. Healthier students also 
have more attendance and higher cognitive functioning, and thus receive a better education 
for a given level of schooling. Furthermore lower mortality rates and higher life expectancy 
encourage savings for retirement, and thus raise investment levels and capital per worker. 
Table A8 in Appendix A gives a synthesis of some of the main studies that explored the 
connection between health and economic prosperity. We discuss here some major results 
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Some scholars assess empirically how health indicators may influence economic returns in 
a specific region using individual or household data while others measure the same effect at 
more aggregated level, between countries or regions. All these studies could be divided 
according to the health indicators considered. Indeed, a number of studies utilize health inputs 
whereas others used health outcomes. Health inputs are the physical factors that influence an 
individual’s health and comprise nutrition variables, exposure to pathogens, and the 
availability of medical care (Weil, 2007). Health outcomes are related to the health status of 
an individual or a given population. These include health indicators broadly considered such 
as life expectancy, mortality indicators, the ability to work hard, and cognitive functioning as 
well as specific illness prevalence such as malaria, AIDS/HIV, Guinea worm, etc.   
Researchers generally conclude that population health remains an important predictor of 
economic outcomes. Life expectancy at birth positively impact economic performances 
(Barro & Lee, 1994; Cuddington & Hancock, 1994; Barro & Sala-I-Martin, 1995; Barro, 
1996; Sach & Warner, 1997; Bloom & Malaney, 1998; Bloom, Canning & Malaney, 2000; 
Arora, 2001; Bloom, Canning & Sevilla, 2005; Acemoglu & Johnson, 2007, 2009; Bloom, 
Canning & Fink, 2009). Bloom et al. (2004) show that life expectancy has a positive, sizable, 
and statistically significant effect on aggregate output even when experience of the workforce 
is controlled for. Sala-i-Martin et al. 2004 departing from the numerous potential explanatory 
variables in cross-country growth regressions, implement a model selection criterion. The set 
of explanatory variables which emerges from the analysis includes human capital variables 
and more especially life expectancy at birth. Acemoglu and Johnson’s results (2007) are less 
conclusive with results indicating that increases in life expectancy have no significant effect 
on output per capita. But their results are still questioned on the choice of an adequate health 
indicator, the limited content of their sample, and the quality of their instrumental variable 
(Acemoglu & Johnson, 2009). 
Mortality or survival variables are also used in the literature as overall health outcome 
indicators that impact economic growth (Hamoudi & Sachs, 1999; Bhargava et al. 2001; 
Bloom & Canning, 2005; Weil, 2007; Lorentzen et al. 2008). Using cross-national and sub-
national data, Lorentzen et al. (2008) argue that high adult mortality rates reduce economic 
growth by shortening time horizons since they favour riskier behaviours, higher fertility rates, 
and lower investments in physical capital. Other authors are also interested in the impact of 
specific diseases on economic returns. In fact, many diseases like HIV/AIDS and malaria are 
found to have a negative effect on the economy (Cuddington & Hancock, 1994; Gallup & al, 
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1999; Bonnel, 2000; Gallup & Sachs, 2001; Sachs, 2003; Bell, Devarajan and Gerbasch 
(2003); McDonald & Roberts, 2006; Audibert et al., 1998, 1999, 2003, 2006, 2009). 
McDonald & Roberts (2006) have calculated that the elasticity of economic growth to 
HIV/AIDS prevalence in Africa is -0.59. Carstensen & Gundlach (2006) found that malaria 
prevalence causes quantitatively important negative effects on income even after controlling 
for institutional quality. Wiping out malaria from sub-Saharan Africa could increase that 
continent’s per capita growth rate by as much as 2.6% a year (Gallup and Sachs, 2001). 
A second strand of the literature assesses the importance of health inputs on development. 
Calories intakes and economic output are positively correlated since richer countries have 
more health inputs than poorer countries: hourly earnings, farm outputs and wages rise with 
increased per capita calorie and protein intakes. Using household-level data from Sierra 
Leone, Strauss (1986) demonstrate that caloric intakes have a highly significant effect on 
labour productivity while Sahn & Alderman (1988) show that calories impact wages. It is 
well-known that malnutrition is detrimental to physical and mental development while both 
have an effect on education, and then on future incomes. Using data on monozygotic twins in 
the USA, Behrman & Rosenzweig (2004) estimate the effect of intrauterine nutrient intake on 
adult health and earnings and thereby evaluate the effectiveness of programs focused on birth 
weights increase. They found that differences in birth weights between identical twins can be 
used to identify the life cycle consequences for physical attributes, schooling, and earnings 
from increasing foetal nutrient intake. 
Another nutrition measurement largely used in the empirical literature is anthropometric 
indicators (Alderman and Behrman, 2006). Several studies show that low birth weights and a 
delay in childhood development (height) have an impact on future wages or labour 
productivity; that taller people tend to be more productive (Deolalikar, 1988; Sahn and 
Alderman, 1998; Strauss and Thomas, 1998; Huffman and Orazem, Berham, 1999; Chapoto 
and Jayne, 2008). A study conducted in rural Zimbabwe shows that improved pre-schooler 
nutritional status, as measured by height for age, is associated with increased height as a 
young adult, a greater number of grades of completed schooling, and an earlier age at which 
the child starts school (Alderman & al. 2006). Indonesian women who are 0.5 cm taller due to 
early-life rainfall shocks complete 0.32 more year of schooling; live in households with 
10.4% higher per capita expenditures and 10.0% higher per capita assets (Maccini & Yang, 
10 
 
2005). Weil (2007) combines micro and macro data and demonstrates that population height 
is an important economic development predictor.7  
Even though malnutrition indicators remain the most health input used in economic 
literature, others indicators are utilized such as treatment, life styles and health services. 
Bleakley (2007) found that areas that had higher levels of malaria or hookworm infection 
prior to eradication experienced greater increases in school attendance and literacy while 
Miguel and Kremer (2005) find that giving de-worming medicines to school children 
improves school participation in Kenya. 
If at a micro-level, numerous studies found that poor health have an economic effect 
through several channels, this effect is less evident at a macro-level. The next section tries to 
deal with that bias.  
4. Empirical framework analysis 
The analysis of the effect of health on economic growth is based on the augmented 
neoclassical growth equation, which includes the global health status variable as a regressor 
combined with initial GDP per capita as catch up variable and other exogenous variables.  
iikii XHealthy ε+δ+β+α=         (1) 
Where yi is the annual growth rate of GDP per capita with subscript i designating the 159 
potential countries included in our sample (see Appendix A7 for the list of the countries); 
Healthi is the global health indicator; Xik the matrix of the k control variables and εi is the 
independently and identically distributed error terms; α, β and δ are parameters to be 
estimated. Moreover regional dummy variables are also included to control for regional 
specific effects. 
Data and variables are presented first and then econometric specification.  
4.1. Data and variables 
The data used in this paper are annual averages over the 1999-2004’s period, since our 
health data are not available apart from these years, and included about 160 WHO member 
states (see list Table A7). The main thesis of this paper is that macroeconomic effects of the 
                                                 
7
 Body Mass Index (BMI measured by weight/height2 and expressed in kg/m2) can also be used. See Thomas & 
Frankenberg (2002) for more details. 
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global health status are accurately caught by the Disability-Adjusted Life Year (DALY) per 
capita calculated by the World Health Organization (WHO). This indicator is proposed by the 
World Bank and WHO since 1993 (the World Bank, 1993). Its represents “a one lost year of 
healthy life and extends the concept of potential years of life lost due to premature death to 
include equivalent years of healthy life lost by virtue of being in states of poor health or 
disability” (WHO, 2008)8. “The sum of these DALYs across the population represents the 
burden of disease and can be thought of as a measurement of the gap between current health 
status and an ideal health situation where the entire population lives to an advanced age, free 
of disease and disability” (WHO, http://www.who.int/healthinfo/global_burden 
disease/metrics_daly/en/). DALYs were calculated initially for about one hundred causes and 
diseases and over the whole word (World Bank, 1993) and were not updated since 1999. 
From1999 to 2004 however, DALYs are also available on a regional basis. DALY figures are 
commonly used in cost-effectiveness analyses but, to the best of our knowledge, have never 
been used in macroeconomic analyses since DALYs by country are only available for 2002 
and 2004. 
Any indicator, including DALYs, is amenable to criticism with a particular emphasis on 
weighting (namely age and disease severity) and discounting (e.g. Anand and Hanson, 1997). 
A large revision has been however implemented, mainly by the Institute of Health Metrics, 
which is in charge DALYs calculations updates and improvements (Lopez et al, 2006). This 
does not prevent however this indicator from being a serious candidate for representing 
population global health status, deriving from illness consequences which are taken into 
consideration in a single indicator. 
DALYs are either available for each WHO 14 regions from 1999 to 2002 and 2004 
(regional DALY) or for each WHO country (country DALY) only in 2002. Weighting the 
WHO regional data by the ratio of the country 2002 DALY to regional 2002 DALY allows 
generating DALY at the country level:9. 
                                                 
8
 The DALYs for each health condition are the sum of the years of life lost (YLL) due to premature mortality 
and the years lost due to disability (YLD) for incident cases of the health condition. YLL are calculated from the 
number of deaths at each age multiplied by a global standard life expectancy for each age. YLD is the number of 
incident cases in a particular period × average duration of the disease × weight factor. The weight factor reflects 
the severity of the disease on a scale from 0 (perfect health) to 1 (death). See WHO (2008). 
9
 Corrected country DALY in t = regional DALY in t * ( 1 + (country 2002 DALY-regional 2002 DALY)/ regional 2002 
DALY)) = regional DALY in t *(country 2002 DALY / regional 2002 DALY). 
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Corrected Country DALY in t = regional DALY in t * (2002 country DALY / 2002 regional 
DALY). 
with t = 1999, 2000, 2001, 2002, 2004 
This correction which increases the number of periods is valid under the hypothesis that the 
gap between the DALY per capita of a country and the DALY per capita of the WHO region 
in which it belongs is constant on the 1999-2004’ period. Such assumption seems rather 
strong but can be justified when one considers that a country’s health conditions can hardly 
evolve over a short period 
The relation between health and growth is estimated either using Corrected Country 
DALYs (CCD) or regional DALYs. DALYs calculated with respect to communicable 
diseases are also considered since communicable diseases, and more specifically, malaria, 
constitute a large part of the disease burden in low and middle income countries. 
We consider several control variables kX , which are either assumed from the theoretical 
model or inferred from other cross-country analyses of Solow augmented growth regressions. 
Initial GDP per capita allows considering conditional convergence when it exhibits a negative 
effect on growth; annual growth rates of population and investment ratio to GDP have resp. a 
negative and positive effect on growth (e.g. Mankiw et al. 1992). In addition to the global 
health indicator, other human capital variables are included. Lagged female school enrollment 
rates are preferred to male school enrollment as it may also reflect the inequality level that has 
an impact on growth. Lagged variables may cope with endogeneity bias. 
A second group of control variables includes the Government consumption ratio to GDP, 
openness and inflation rates. The government consumption does not have a clear-cut effect on 
growth (Barro, 1990). Openness and inflation allows taking economic policy variables with 
resp. a positive and a negative effect on growth. A variable taken from ICRG allows including 
institutional quality which positively affects growth.  
The characteristics of each variable are reported in Table A1, Appendix A. This table is 
completed by Table A2 in Appendix A which presents the correlations between important 
variables used in this paper. 
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4.2. Econometric specification 
OLS estimation of equation (1) is potentially biased. First there can be a simultaneity bias 
between global health status and growth (e.g. Bonnel 2000; Bloom, Canning and Malaney 
2000; Sachs et al. 1999, 2003; Strauss and Thomas, 2008; Schultz, 2008). Measurement errors 
of the global health indicator may also induce biased estimators. To deal with these problems, 
we draw on instrumental variables techniques and therefore identify two instruments.  
The first is malaria ecology developed by Kiszewski and Sachs et al. (2004) and first used 
for cross-country regressions by Sachs (2003) and Carstensen and Gundlach (2006). Malaria 
ecology is built upon climatic factors and specific biological properties of each regionally 
dominant malaria vector which only reflects the forces of biological evolution and is thus 
independent from present health interventions and economic conditions. Moreover germs 
likely to be affected by economic conditions or public health interventions (like mosquito 
abundance, for example) do not enter the calculation of the index (Kiszewski and Sachs et al. 
2004; Carstensen and Gundlach 2006).  
The other instrument used in this paper is the proportion of each country’s population 
threatened by a risk of malaria transmission in 1994. This indicator affects current economic 
growth only through health status and is unlikely affected by current economic conditions.  
5. Econometric results 
Equation (1) is estimated with the heteroskedastic-efficient two-step generalized method of 
moments (IV-GMM) estimator which generates efficient coefficients as well as consistent 
standard errors estimates. (Hayashi 2000 pp.206-13 and 226-27; Baum et al. 2007). 
5.1. Main results 
Results of GMM estimations are presented in Table 1 below. The first column reports 
estimates with corrected DALYs. Our instruments are either validated by the Shea R² and 
Hansen over-identification test or the first stage estimation results presented Table A4 
(Appendix A). Contrary to OLS estimates,10 Health is found to have a negative and 
statistically significant effect on economic growth thus validating the attenuation bias. This 
result is robust to variants of DALYs (columns 2 to 4). The effect of communicable diseases 
DALYs (col. 4) may reflect the importance of communicable diseases in health status in the 
                                                 
10
 OLS estimates of equation (1) are reported in Table A3, Appendix A. 
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world that are yet now the main causes of DALYs losses in developing and transitional 
countries. By contrast, the coefficient of DALYs for malaria is lower (-0,011), indicating that 
malaria is just one among other health main causes. 
Table 1. Two-step GMM estimation of economic effects of DALYs per capita 
 
 Dependent variable: GDP per capita growth 
Variables (1) (2) (3) (4) (5) 
      
Log Corrected DALYs -0.036***     
 
(3.51)     
Log Regional DALYs  -0.056**    
 
 (2.54)    
Log DALYs in 2002   -0.036***   
 
  (3.48)   
Log Communicable DALYs    -0.040**  
 
   (2.12)  
Log Malaria DALYs     -0.011** 
 
    (2.57) 
Log initial GDP per capita -0.015*** -0.016*** -0.015*** -0.024*** -0.015*** 
 
(5.05) (4.11) (5.02) (3.09) (4.07) 
Investment ratio to GDP 0.105** 0.130*** 0.105** 0.139*** 0.154*** 
 
(2.45) (3.07) (2.45) (2.83) (3.60) 
Population growth rate 0.327 0.171 0.314 0.266 0.558* 
 
(0.98) (0.49) (0.93) (0.62) (1.68) 
Government consumption -0.003 -0.042 -0.003 -0.100 -0.057 
 
(0.07) (0.85) (0.08) (1.39) (1.13) 
Openness 0.003 0.005 0.004 0.002 0.001 
 
(1.27) (1.43) (1.35) (0.55) (0.15) 
Inflation rate -0.024* -0.025 -0.025* -0.025* -0.032** 
 
(1.72) (1.54) (1.71) (1.67) (2.51) 
Female School enrollment lag -0.013 -0.002 -0.013 0.008 0.003 
 (1.26) (0.19) (1.29) (0.55) (0.26) 
Institutions 0.110 0.103 0.104 0.143 0.135 
 (0.67) (0.61) (0.63) (0.72) (0.76) 
Constant 0.308*** 0.444*** 0.308*** 0.361** 0.097*** 
 (3.84) (2.77) (3.82) (2.38) (2.73) 
Regional dummies Yes yes yes yes yes 
Observations 124 124 124 124 124 
R² 0.301 0.130 0.296 -0.242 0.202 
Shea partial R² 0.365 0.163 0.364 0.080 0.145 
Hansen OID p-value 0.325 0.314 0.297 0.481 0.433 
Note: Health variables are instrumented by Malaria Ecology and Malaria Risk.  
***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics enter parenthesis.  
The GMM estimator is preferred than 2SLS in the estimations of the parameters. 
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These results are in conformity with some important previous works (Bloom et al. 2004). 
They stress that a global health indicator is an important predictor of economic development 
on a large sample of poor and rich countries. They also underline the importance of the 
identification strategy in the assessment of the economic effect of health status.  
One could argue that explanatory variables such as investment rate and Government 
expenditure are also endogenous. The endogeneity of these variables comes from the reverse 
causality since rich countries are able to invest and spend in consumption. To solve for this, 
we instrument these variables with their value in previous period. The results obtained are 
summarized in Table 2 and the first stage estimation results are presented in Table A6 
Appendix A. 
The effect of health indicators remains negative and statistically significant with very 
similar even though the coefficients.  
16 
 
Table 2. Two-step GMM estimation of economic effects of DALYs per capita, instrumenting 
Government expenditure 
 Dependent variable: GDP per capita growth gdpgrowth 
gdpgrowth Variables (1) (2) (3) (4) (5) 
      
Log Corrected DALYs -0.038***     
 
(3.71)     
Log Regional DALYs  -0.056***    
 
 (2.64)    
Log DALYs in 2002   -0.038***   
 
  (3.67)   
Log Communicable DALYs    -0.038**  
 
   (2.32)  
Log Malaria DALYs     -0.011*** 
 
    (2.79) 
Log initial GDP per capita -0.016*** -0.017*** -0.016*** -0.024*** -0.016*** 
 
(5.26) (4.22) (5.21) (3.42) (4.49) 
Investment ratio to GDP 0.058 0.100 0.059 0.149* 0.156** 
 
(0.75) (1.38) (0.77) (1.76) (2.13) 
Population growth rate 0.291 0.174 0.275 0.323 0.569* 
 
(0.86) (0.49) (0.81) (0.77) (1.74) 
Government consumption 0.018 0.009 0.018 -0.044 -0.036 
 
(0.41) (0.16) (0.42) (0.63) (0.66) 
Openness 0.004 0.006 0.004 0.002 0.001 
 
(1.36) (1.53) (1.43) (0.52) (0.13) 
Inflation rate -0.025 -0.026 -0.025 -0.025 -0.030** 
 
(1.53) (1.51) (1.52) (1.53) (2.10) 
Female school enrollment lag -0.010 -0.001 -0.010 0.006 0.003 
 
(0.98) (0.12) (1.02) (0.43) (0.23) 
Institution 0.148 0.113 0.142 0.138 0.154 
 
(0.85) (0.64) (0.82) (0.67) (0.82) 
Constant 0.334*** 0.443*** 0.333*** 0.339*** 0.094*** 
 
(3.95) (2.92) (3.92) (2.64) (2.72) 
Observations 123 123 123 123 123 
R² 0.279 0.126 0.275 -0.192 0.200 
Shea partial R² of health variable 0.371 0.177 0.371 0.099 0.168 
Shea partial R² of investment 0.440 0.453 0.440 0.452 0.447 
Shea partial R² of Gov. Cons. 0.750 0.758 0.749 0.691 0.688 
Hansen OID p-value 0.233 0.215 0.211 0.410 0.409 
Note: Health variables are instrumented by Malaria Ecology and Malaria Risk. Investment ratio and Government 
Consumption are instrumented by their lag. 
***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics enter parenthesis.  
The GMM estimator is preferred than 2SLS in the estimations of the parameters. 
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5.2. Robustness analyses 
Our previous results relying on the IV technique may still be questioned. First, they may be 
due to the large health outcome gap between developed and developing countries, and may 
not satisfactorily explain development levels gaps between developing or developed 
countries. Secondly, it is relevant to investigate the role of health in the explanation of 
development differential within countries which share a common characteristic related to poor 
basic health infrastructures. Equation (1) is therefore estimated on a low and middle-income 
countries sub-sample of which results are presented in Table 3 and the first stage estimation 
results are presented in Table A6 Appendix A. They are similar to those obtained for the 
whole sample, namely, health remains an important determinant of economic growth, even 
coefficients are smaller than those previously obtained (0,021 against 0,0036 for Corrected 
DALYs; 0,006 against 0,011 for Malaria DALYs). 
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Table 3: Two-step GMM estimation of economic effects of DALYs per capita, developing 
countries 
 Dependent variable: GDP per capita growth 
Variables (1) (2) (3) (4) (5) 
Log Corrected DALYs -0.021**     
 
(2.08)     
Log Regional DALYs  -0.031*    
 
 (1.86)    
Log DALYs in 2002   -0.020**   
 
  (2.07)   
Log Communicable DALYs    -0.018*  
 
   (1.91)  
Log Malaria DALYs     -0.006* 
 
    (1.72) 
Log initial GDP per capita -0.013*** -0.012*** -0.013*** -0.012*** -0.010*** 
 
(3.43) (3.41) (3.42) (3.31) (3.38) 
Investment ratio to GDP 0.115** 0.128*** 0.115** 0.139*** 0.150*** 
 
(2.51) (2.93) (2.50) (3.38) (3.71) 
Population growth rate 0.243 0.251 0.235 0.355 0.414 
 
(0.60) (0.61) (0.58) (0.87) (1.02) 
Government consumption 0.060 0.038 0.060 0.018 0.018 
 
(1.17) (0.80) (1.16) (0.38) (0.40) 
Openness -0.009 -0.007 -0.009 -0.011* -0.009 
 
(1.54) (1.13) (1.51) (1.66) (1.62) 
Inflation rate -0.032** -0.031** -0.032** -0.031** -0.033** 
 
(2.22) (2.05) (2.22) (2.26) (2.31) 
Female school enrollment lag -0.007 -0.002 -0.007 -0.000 -0.004 
 
(0.76) (0.19) (0.78) (0.04) (0.42) 
Institution 0.147 0.175 0.143 0.212 0.207 
 
(0.90) (1.07) (0.87) (1.31) (1.27) 
Constant 0.197** 0.251** 0.195** 0.156** 0.054 
 
(2.39) (2.16) (2.37) (2.25) (1.52) 
Observations 87 87 87 87 87 
R² 0.511 0.476 0.509 0.495 0.550 
Shea partial R² 0.425 0.236 0.428 0.205 0.243 
Hansen OID p-value 0.261 0.262 0.246 0.288 0.202 
Note: Health variables are instrumented by Malaria Ecology and Malaria Risk.  
***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics enter parenthesis. 
The GMM estimator is preferred than 2SLS in the estimations of the parameters. 
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6. Concluding remarks 
This study contributes to the debate on the relationship between health outcomes and 
economic performance by paying a particular attention to global health status measurement 
issues. We argue that, traditional health indicators such as life expectancy and mortality rates 
are inadequate to explain the overall health status in a population since they present many 
drawbacks and are devoted to a particular health problem. An accurate health indicator must 
measure the gap between current health status and an ideal health situation where the entire 
population lives to an advanced age, free of diseases and disabilities. This aspect is 
specifically addressed by the disability-adjusted life year (DALY) proposed by the World 
Bank and WHO. Using this indicator in an augmented Solow growth model, the results show 
that global health outcomes as well as less aggregated health measurement (communicable 
diseases and malaria) remain important predictors of economic development. Our results are 
similar to those found in previous literature, even though they still contradict recent works 
such as Acemoglu and Robinson’s (2009).  
Our results support the idea improving health status is a prerequisite for development, and 
will contribute to play a role in poverty reduction (Dodd and Cassels, 2006; WHO, 2004). 
Health issues represent a challenge rather than a handicap. For example reducing malaria 
prevalence and other communicable diseases by paying more attention to water and sanitation 
is an effective way to improve growth performances.  
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Appendix A 
 
Table A1: Variables characteristics and source 
  mean min Max coef. 
Var. 
sd N   Source 
gdp. Growth 0,04 -0,05 0,10 0,62 0,02 159  WDI 2007 
log corrected Daly 5,42 4,59 6,86 0,11 0,58 159  WHO 
log Daly 2002 5,42 4,59 6,85 0,11 0,57 159  WHO 
log Comm. Disease 3,89 1,48 6,61 0,39 1,53 159  WHO 
log Malaria -0,65 -8,87 4,30 -5,69 3,70 121  Sachs 2003 
Mal. Ecology 3,84 0,00 31,55 1,76 6,77 149  Sachs 2003 
Mal. Risk 0,31 0,00 1,00 1,34 0,42 145  Sachs 2003 
pop. Growth 1,42 -1,11 7,03 0,84 1,19 159  WDI 2007 
invest. 0,21 0,08 0,55 0,31 0,07 159  WDI 2007 
gov. Expend. 0,16 0,05 0,55 0,39 0,06 159  WDI 2007 
Openness 0,87 0,21 3,92 0,55 0,48 159  WDI 2007 
Inflation 0,08 -0,01 1,20 1,76 0,14 159  WDI 2007 
School 0,93 0,22 1,30 0,23 0,21 159  UNICEF 
Institution 0,08 0,03 0,12 0,24 0,02 126   ICRG 
 
 
 
Table A2: Correlation between the main variables 
  GDP growth 
Corrected 
Daly Investment Pop.growth 
Gov. 
Expend. Openness Inflation 
        
Corrected Daly 0.04 1      
fbcf 0.27*** -0.16** 1     
pop.growth 0.03 0.47*** -0.18** 1    
Gov. Expend. -0.24*** -0.21*** 0.12 -0.11 1   
openness 0.11 -0.23*** 0.25*** -0.13* 0.19** 1  
inflation -0.18** 0.24*** -0.16** -0.02 -0.06 -0.08 1 
school -0.12 -0.55*** 0.15** -0.41*** 0.10 0.17** 0.02 
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Table A3: OLS estimation of the economic effects of health status 
 Dependent variable: GDP per capita growth 
Variables (1) (2) (3) (4) (5) 
      
Log Corrected DALYs -0.009     
 (1.39)     
Log Regional DALYs  -0.001    
  (0.15)    
Log DALYs in 2002   -0.008   
   (1.29)   
Log Communicable DALYs    0.001  
    (0.16)  
Log Malaria DALYs     -0.002 
     (1.34) 
Log initial GDP per capita -0.008*** -0.006*** -0.008*** -0.006** -0.008*** 
 (3.42) (2.74) (3.35) (2.46) (3.56) 
Investment ratio to GDP 0.130*** 0.141*** 0.131*** 0.141*** 0.142*** 
 (3.25) (3.55) (3.26) (3.57) (3.61) 
Population growth rate 0.282 0.259 0.277 0.257 0.324 
 (1.24) (1.14) (1.22) (1.12) (1.40) 
Government consumption -0.008 -0.013 -0.009 -0.012 -0.019 
 (0.21) (0.33) (0.22) (0.29) (0.47) 
Openness 0.004 0.004 0.004 0.004 0.003 
 (1.02) (1.10) (1.04) (1.12) (0.90) 
Inflation rate -0.032** -0.034*** -0.032** -0.035*** -0.034*** 
 (2.46) (2.64) (2.48) (2.68) (2.65) 
Female school enrollment lag -0.005 -0.004 -0.005 -0.004 -0.003 
 (0.49) (0.34) (0.48) (0.36) (0.24) 
Institution 0.050 0.030 0.047 0.026 0.047 
 (0.36) (0.21) (0.34) (0.19) (0.34) 
Constant 0.103* 0.045 0.099* 0.033 0.046* 
 (1.95) (0.76) (1.86) (0.94) (1.93) 
Regional dummy yes yes yes yes yes 
Observations 126 126 126 126 126 
R² 0.394 0.384 0.393 0.384 0.393 
***significant at 1%, **significant at 5%, *significant at 10%.  Robust t-statistics enter parenthesis 
 Health variable is represented by corrected DALYs (column 1), WHO regional level DALYs (columns 2), 
country level 2002 DALYs (columns 3), DALYs for communicable diseases (column 4) and DALYs for malaria 
(column 5). 
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Table A4: first stage estimation results (whole sample) ++ 
 Dependent variables 
(1) (2) (3) (4) (5) 
Excluded 
instruments 
Corrected 
DALYS 
per capita 
Log 
Regional 
DALYs 
Log 
DALYs 
in 2002 
Log Commu- 
Nicable 
DALYs 
Log Malaria 
DALYs 
Malaria Ecology 0.014* 0.010* 0.014* 0.012 0.047 
 (1.83) (1.75) (1.94) (1.22) (1.54) 
Malaria Risk 0.523*** 0.247** 0.513*** 0.426* 1.490** 
 (3.77) (2.04) (3.71) (1.89) (2.17) 
N 124 124 124 124 124 
Note: ***significant at 1%; **significant at 5%; *significant at 10%.  t-statistics in parenthesis. 
++ We show only the coefficients of the instruments, but all the exogenous variables are included in 
the regressions 
 
 
 
Table A5: First stage estimation results (health, investment and Gover. Consump. variables instrumented) ++ 
 Dependent variables 
 (1) (4) (5) (6) (7) (2) (3) 
instruments 
Corrected 
DALYS 
per capita 
Log 
Regional 
DALYs 
Log 
DALYs 
in 2002 
Log 
Communicable 
DALYs 
Log 
Malaria 
DALYs 
Investment 
ratio 
Government 
Consumption 
Malaria Ecology 0.012* 0.011* 0.013* 0.014 0.049 0.001 -0.001 
 (1.66) (1.77) (1.76) (1.36) (1.52) (0.82) (0.85) 
Malaria Risk 0.563*** 0.261** 0.554*** 0.468** 1.647** -0.016 0.010 
 (4.25) (2.13) (4.19) (2.04) (2.35) (0.96) (0.87) 
Investment lag -0.018 0.223 -0.028 1.390 5.326* 0.637*** 0.026 
 (0.04) (0.48) (0.06) (1.31) (1.82) (7.93) (0.53) 
Govern. 
Consump. lag 0.706 0.218 0.740 -0.836 -2.688 -0.011 0.831
***
 
 (1.41) (0.42) (1.48) (0.70) (0.90) (0.15) (15.55) 
N 123 123 123 123 123 123 123 
Note: ***significant at 1%; **significant at 5%; *significant at 10%.  t-statistics in parenthesis. 
++ We show only the coefficients of the instruments, but all the exogenous variables are included in the regressions 
 
 
 
 
 
 
 
 
 
29 
 
Table A6: first stage estimation results (Developing countries) ++ 
 (1) (2) (3) (4) (5) 
Instruments Corrected 
DALYS per 
capita 
Log Regional 
DALYs 
Log DALYs 
in 2002 
Log Communicable 
DALYs 
Log Malaria 
DALYs 
Malaria_Ecology 0.009 0.008 0.010 0.012 0.056 
 (1.42) (1.26) (1.56) (1.06) (1.64) 
Malaria Risk  0.652*** 0.364*** 0.646*** 0.697*** 1.454** 
 (5.85) (2.66) (5.87) (2.82) (2.15) 
Observations 87 87 87 87 87 
Note: ***significant at 1%; **significant at 5%; *significant at 10%.  t-statistic in parenthesis. 
++ We show only the coefficients of the instruments, but all the exogenous variables are included in the regressions 
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Table A7: List of countries 
country list 
Albania   Ghana   Panama 
Algeria   Greece  Papua New Guinea 
Argentina   Grenada  Paraguay 
Armenia   Guatemala  Peru 
Australia   Guinea  Philippines 
Austria   Guinea-Bissau  Poland 
Azerbaijan   Guyana  Portugal 
Bahrain   Haiti  Romania 
Bangladesh   Honduras  Russian Federation 
Belarus   Hungary  Rwanda 
Belgium   Iceland  Saudi Arabia 
Belize   India  Senegal 
Benin   Indonesia  Seychelles 
Bhutan   Iran, Islamic Rep.  Sierra Leone 
Bolivia   Ireland  Singapore 
Bosnia and Herzegovina   Israel  Slovak Republic 
Botswana   Italy  Slovenia 
Brazil   Jamaica  Spain 
Bulgaria   Japan  Sri Lanka 
Burkina Faso   Jordan  St. Kitts and Nevis 
Burundi   Kazakhstan  St. Lucia 
Cambodia   Kenya  St. Vincent and the Grenadines 
Cameroon   Korea, Rep.  Sudan 
Canada   Kuwait  Suriname 
Cape Verde   Kyrgyz Republic  Swaziland 
Central African Republic   Latvia   Sweden 
Chad   Lebanon   Switzerland 
Chile   Lesotho   Syrian Arab Republic 
China   Liberia   Tajikistan 
Colombia   Lithuania   Tanzania 
Comoros   Luxembourg   Thailand 
Congo, Dem. Rep.   Macedonia, FYR   Togo 
Congo, Rep.   Madagascar   Tonga 
Costa Rica   Malawi   Trinidad and Tobago 
Cote d'Ivoire   Malaysia   Tunisia 
Croatia   Maldives   Turkey 
Cyprus   Mali   Uganda 
Czech Republic   Malta   Ukraine 
Denmark   Mauritania   United Arab Emirates 
Djibouti   Mauritius   United Kingdom 
Dominica   Mexico   United States 
Dominican Republic   Moldova   Uruguay 
Ecuador   Mongolia   Uzbekistan 
Egypt, Arab Rep.   Morocco   Vanuatu 
El Salvador   Mozambique   Venezuela, RB 
Eritrea   Namibia   Vietnam 
Estonia   Nepal   Yemen, Rep. 
Ethiopia   Netherlands   Zambia 
Fiji   New Zealand   Zimbabwe 
Finland   Nicaragua     
France   Niger     
Gabon   Nigeria     
Gambia, The   Norway     
Georgia   Oman     
Germany   Pakistan     
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Table A8: Literature review on the effect of health on economic growth 
 
Study year Health 
measure 
Coeffient 
(standard 
error) 
data Estimator Journal Other covariates 
Barro and 
Lee 1994 
Life 
expectancy 
0.073 
(0.013) 
Two periods 
n=85 for 
1965–75, 
n=95 for 
1975–85 
SUR with country 
random effects 
Harvard 
University, 
Cambridge, MA 
02138, USA 
Male and female secondary 
schooling, I/GDP, G/GDP, 
log(1+black market 
premium), revolutions 
Cuddington 
John T.  and 
Hancock 
John D.  
1994 AIDS 
0.2- 0.3% 
points lost 
in the 
medium 
case and 
1.2- 1.5 in 
the lower 
case 
Each five 
year age 
cohort from 
1985-2010 
in Malawi 
simulation 
Journal of 
Development 
Economics 43, 
363-368 
Na 
Barro and 
Sala IMartin  1995 
Life 
expectancy 
0.058 
(0.013) 
Two periods 
n=87 for 
1965–75, 
n=97 for 
1975–85 
SUR with country 
random effects 
New York: 
McGraw-Hill 
Male and female secondary 
and higher education, 
log(GDP) · human capital, 
public spending on 
education/ GDP, 
investment/GDP, 
government 
consumption/GDP, 
log(1+black market 
premium), political 
instability, growth rate in 
terms of trade 
Barro 1996 Life 
expectancy 
0.042 
(0.014) 
Three 
periods 
1965–75, 
n=80; 1975–
85, n=87; 
1985–90, 
N=84 
3SLS using lagged 
values of some 
regressions as 
instruments, period 
random effects 
NBER working 
paper series 
Male secondary and higher 
schooling, log(GDP) · male 
schooling, log fertility rate, 
government consumption 
ratio, rule of law index, 
terms of trade change, 
democracy index, demo- 
cracy index squared, 
inflation rate, continental 
dummies 
Caselli, 
Esquivel, 
and Lefort 
1996 Life 
expectancy 
-0.001 
(0.032) 
25-year 
panel at 5-
year 
intervals, 
1960–85, 
n=91 
GMM (Arellano- 
Bond method) 
Journal of 
Economic 
Growth, 1, 363-
389. 
Male and female schooling, 
I/GDP, G/GDP, black 
market premium, 
revolutions 
Life 
expectancy 
45.48 
(2.60) Sachs and 
Warner 1997 
life 
expectancy 
squared 
-5.40  
(2.41) 
25-year 
cross-
section, 
N=79 
OLS 
Journal of 
African 
Economies, 
December 1997, 
Volume 6, 
Number 3, pp. 
335-376 
Openness, openness 
xlog(GDP), land-locked, 
government saving, tropical 
climate, institutional 
quality, natural resource 
exports, growth in 
economically active 
population minus 
population growth 
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Study year Health 
measure 
Coeffient 
(standard 
error) 
data Estimator Journal Other covariates 
Bloom and 
Sachs 1998 
Life 
expectancy 
0.037 
(0.011) 
25-year 
cross-
section, 
1965–90, 
n=65 
OLS 
Brooking Papers 
on Economic 
Activities, 2, 
207-273 
Log secondary schooling, 
openness, institutional 
quality, central government 
deficit, percentage area in 
tropics, log coastal 
population density, log 
inland population density, 
total population growth 
rate, working- age 
population growth rate, 
Africa dummy 
Bloom and 
Malaney  1998 
Life 
expectancy 
0.027 
(0.107) 
25-year 
cross-
section, 
1965–90, 
n=77 
OLS 
World 
Development, 
Vol. 26, No. 11. 
pp. 2073-2085, 
1998 
Population growth, growth 
of economically active 
populations, log years of 
secondary schooling, 
natural resource abundance, 
openness, institutional 
quality, access to ports, 
average government 
savings, tropics, ratio of 
coastline distance to land 
area 
Bloom and 
Williamson  1998 
Life 
expectancy 
0.040 
(0.010) 
25-year 
cross-
section, 
1965–90, 
n=78 
OLS 
World Bank 
Economic 
Review, 12(3), 
419-455 
Population growth rate, 
working- age population 
growth rate, log years of 
secondary schooling, 
natural resource abundance, 
openness, institutional 
quality, access to port, 
average government 
savings rate, tropics 
dummy, ratio of coastline to 
land area 
life 
expectancy 2.4  (1.34) Gallup J. L., 
Sachs J. D. 
and 
Mellinger A. 
D. 
1999 
Malaria 
index 1966 -2.6  (0.67) 
25-year 
cross-
section, 
1965–90, 
n=75 
2SLS with malaria 
idex instrument by 
temperate 
(temperate, boreal, 
and polar ecozones), 
desert (tropical and 
subtropical deserts), 
subtropical 
(nondesert 
subtropical), and 
tropical (nondesert 
tropical) 
International 
Regional 
Science Review 
22, 2: 179–232 
Years of secondary 
schooling, openness, quality 
of public institutions, 
population within 100 
kilometers of the coast, 
malaria index in 1966, 
change in malaria index 
from 1966 to 1994 
Life 
expectancy 
0.072 
(0.020) Hamoudi 
Amar A. and  
Sachs Jeffrey 
D. 
1999 
Infant 
mortality 
rate 
-0.0002  
(0.00008) 
15-year 
cross-
section, 
1980–95, 
n=78 
OLS CID Working Paper No. 30 
Institutional quality, 
openness, net government 
savings, tropics land area, 
log coastal population 
density, population growth 
rate, working-age 
population growth rate, 
Africa dummy 
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Study year Health 
measure 
Coeffient 
(standard 
error) 
data Estimator Journal Other covariates 
Bloom, 
Canning and 
Malaney 
2000 Life 
expectancy 
0.019 
(0.012) 
25-year 
cross 
section, 
1965–90, 
n=80 
2SLS 
Population and 
Development 
Review, 
26(supp.), 257– 
290 
Log of ratio of total 
population to working-age 
population, tropics, log of 
years of secondary 
schooling, openness, 
institutional quality, 
population growth rate, 
working age population 
growth rate 
Bonnel René 2000 HIV/AIDS 
-0.7% 
points per 
year 
1990- 1997 
african 
countries 
OLS and 2SLS  World bank 
Log GDP 1990, Log phone 
per capita, Macro rating, 
Law rating, Primary 
enrollment rate, Malaria 
morbidity and dummy 
Ranis Gustav 
and Steward 
Frances  
2000 Life 
expectancy 
0.06 
(0.016) 
N=73 
developing 
countries 
Cross 
country 
1960-1992 
2SLS using lagged 
values as intruments 
World 
Development 
Vol. 28, No. 2, 
pp. 197-219, 
2000 
change in the log of life 
expectancy 1962-82, gross 
domestic investment, 
income distribution, 
regional dummies, 
Adult 
survival rate 
0.358 
(0.114) 
Bhargava, 
Jamison, 
Lau, and 
Murray 
2001 
 ASR xlog 
(GDPC) 
-0.048 
(0.016) 
25-year 
panel at 5-
year 
intervals, 
1965–90, n= 
92 
Dynamic random 
effects 
Journal of 
Health 
Economics 20 
(2001) 423–440 
Tropics, openness, log 
fertility, log 
(Investment/GDP) 
Mayer David 2001 
Probability 
of survival 
by age and 
gender 
groups 
0,8 and 
1,5% 
Panel of 18 
countries 
over 1975, 
1980 and 
1985 
 Granger-type 
causality tests 
World 
Development 
Vol. 29, No. 6, 
pp. 1025–1033, 
2004 
Schooling, investment, 
Government consumption 
and fertility 
falciparum 
malaria 
index 
-2.5   (0.71) Gallup J. L. 
and Sachs J. 
D. 
2001 
life 
expectancy 3.0  (0.84) 
25-year 
cross-
section, 
1965–90, 
n=75 
2SLS with the 
prevalence of 53 
different Anopheles 
mosquito vectors in 
each country in 
1952 as instrument 
American 
Journal of 
Tropical  
Medicine and 
Hygiene, 64 (1, 
2)S 85-96 
Years of secondary 
schooling, openness, quality 
of public institutions, 
population within 100 
kilometers of the coast, 
malaria index in 1966, 
change in malaria index 
from 1966 to 1994 
Suchit Arora 2001 
Stature at 
Adulthood, 
Life 
Expectancy 
30- 40% 
10 
developed 
countries 
over the 
course of 
100 to 125 
years 
Cointegration and 
Error-Correction 
The Journal of 
Economic 
History, Vol. 
61, No. 3 (Sep., 
2001), pp. 699-
749 
Na 
Sachs Jeffrey 
D.  2003 Malaria Risk -1.43 (0.35) 
Cross- 
country 
regression in 
1995, 
N=101 
2SLS with Malaria 
Ecology as 
instrument 
Working Paper 
9490 rules of law 
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Study year Health 
measure 
Coeffient 
(standard 
error) 
data Estimator Journal Other covariates 
Bloom David 
E.,  Canning 
David and 
Sevilla 
Jaypee  
2004 Life 
expectancy 
0.040  
(0.019) 
every 10 
years from 
1960 to 
1990 
Nonlinear two stage 
least squares with 
lagged as instrument 
World 
Development 
Vol. 32, No. 1, 
pp. 1–13, 2004 
Capital, labor, Schooling, 
Experience, Technological 
catch-up coefficient, 
Percentage of land area in 
the tropics and Governance 
Health 
services,   
0,0021    
(0.006) 
Lifestyles 0.0016 (0.0002) 
 Aguayo-
Rico Andrés, 
Guerra-
Turrubiates 
Iris A.  
2005 
total health 
index 
0.0015 
(0.0001) 
N=104 panel 
1970, 1980 
and 1990 
OLS 
Political 
Economy, Vol. 
14, August 2005 
capital, labor, schooling, 
Environment 
David E. 
Bloom and 
David 
Canning 
2005 Adult 
survival rate 
0.03 
(0.009) 
5 years 
panel from 
1960 to 
1995 
OLS CDDRL 
working paper 
capital, labor, schooling, 
Environment, 
Technological catch-up 
coefficient, Percentage of 
land area in the tropics, 
Openness, Percentage oft 
land within 100 kilometers 
of the coast, Ethno-
linguistic fractionalization, 
Institutional quality 
adult 
mortality 
rate 
-8.564  
(2.23) 
crude death 
rate 
-145.765  
(64.78) 
Lorentzen 
Peter,  
McMillan 
John and 
Wacziarg 
Romain  
2005 
infant 
mortality 
rate 
-31.644  
(6.92) 
cross-
country 
1960-2000  
2SLS with maiaria 
ecology, climatic 
factors and 
geographic 
caracteristic as 
instruments 
Working Paper 
11620 
investment, education, 
Government consumption, 
openness, population, 
interstate battle death 
Acemoglu 
Daron  and 
Johnson 
Simon  
2006 Life 
expectancy -1.43 (2.24) 
Panel 1940-
1980, 
N=234 and 
47 countries 
2SLS with predicted 
mortality, as 
instrument 
NBER Working 
Paper 12269 
Population, investment, 
education 
Carstensen 
Kai and 
Gundlach 
Erich  
2006 Malaria risk -1.31 (0.42) 
Cross 
country of 
45 countries 
2SLS with maiaria 
ecology as 
instrument 
The World 
Bank Economic 
Review, vol. 20, 
N°3 
Institutional quality, 
climatic factors and 
geographic characteristic 
McDonald 
Scott  and 
Roberts 
Jennifer  
2006 HIV/AIDS -0.59% 
Panel of 
each five 
year from 
1960 to 
1998 for all 
countries. 
2SLS with lagged as 
instruments and 
GMM 
Journal of 
Development 
Economics 80 
(2006) 228– 250 
Income per capita, 
investment, population 
growth, schooling, proteins, 
malaria, infant mortality, 
life expectancy. 
Weil David 
N.  2007 
height, adult 
survival 
rates, and 
age at 
menarche 
9.9-12.3% 
income 
variation 
explained 
by health  
cross- 
country 
regression in 
1996, N=73 
2SLS with health 
inputs as 
instruments 
the Quaterly 
Journal of 
Economics, vol. 
122, N°3, 1265- 
1306 
investment, education 
 
